Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Modern Rheumatology|June 6, 2023
Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to ACR/EULAR 2022 classification criteriaKen-Ei Sada, Kenji Nagasaka, Shinya Kaname, et al.
Modern Rheumatology|December 17, 2021
Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour and Welfare DatabaseKenji Nagasaka, Shinya Kaname, Koichi Amano, et al.
Inflammation|February 24, 2024
Relationship Between the Lipidome Profile and Disease Activity in Patients with Rheumatoid ArthritisShotaro Masuoka, Junko Nishio, Soichi Yamada, et al.
Modern Rheumatology|November 17, 2016
Simplified Disease Activity Index remission at month 6 is an independent predictor of functional and structural remissions at month 12 during abatacept treatment in patients with rheumatoid arthritis: A multi-center, prospective cohort study in JapanHayato Yamazaki, Fumio Hirano, Tsutomu Takeuchi, et al.
Arthritis and Rheumatism|December 4, 2012
Am80, a retinoic acid receptor agonist, ameliorates murine vasculitis through the suppression of neutrophil migration and activationChie Miyabe, Yoshishige Miyabe, Noriko N Miura, et al.
AJR. American Journal of Roentgenology|April 12, 2019
Chest High-Resolution CT Findings of Microscopic Polyangiitis: A Japanese First Nationwide Prospective Cohort StudyAika Suzuki, Susumu Sakamoto, Atsuko Kurosaki, et al.
Arthritis and Rheumatism|May 14, 2013
Necessity of lysophosphatidic acid receptor 1 for development of arthritisYoshishige Miyabe, Chie Miyabe, Yoshiko Iwai, et al.
Methods and Protocols|November 29, 2021
Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications, Subclinical AtherosclerosisTomoaki Ishigami, Toshihiro Nanki, Takuya Sugawara, et al.
Pulmonary Pharmacology & Therapeutics|February 9, 2011
Tacrolimus-induced pulmonary injury in rheumatoid arthritis patientsRyuji Koike, Michi Tanaka, Yukiko Komano, et al.
Rheumatology International|May 24, 2014
The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) databaseRyoko Sakai, Soo-Kyung Cho, Toshihiro Nanki, et al.
Pageof 13